As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.
Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.